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Introduction: Acute kidney injury (AKI) is common among intensive care unit (ICU) patients, but follow-up data on
subsequent risk of cardiovascular disease remain sparse. We examined the impact of AKI on three-year risk of
first-time heart failure, myocardial infarction (MI), and stroke among ICU patients surviving to hospital discharge, and
whether this risk is modified by renal recovery before hospital discharge.
Methods: We used population-based medical registries to identify all adult patients admitted to an ICU in Northern
Denmark between 2005 and 2010 who survived to hospital discharge and who had no previous or concurrent
diagnosis of heart failure, MI, or stroke. AKI was defined according to the creatinine criteria in the Kidney Disease
Improving Global Outcomes classification. We computed the three-year cumulative risk of hospitalization with heart
failure, MI, and stroke for patients with and without AKI and the hazard ratios (HRs), using a Cox model adjusted for
potential confounders.
Results: Among 21,556 ICU patients surviving to hospital discharge, 4,792 (22.2%) had an AKI episode. Three-year
cumulative risk of heart failure was 2.2% in patients without AKI, 5.0% for AKI stage 1, and 5.0% for stages 2 to 3.
The corresponding adjusted HRs were 1.33 (95% confidence interval (CI), 1.06 to 1.66) for patients with AKI stage 1
and 1.45 (95% CI, 1.14 to 1.84) for AKI stages 2 to 3, compared to patients without AKI. The three-year cumulative
MI risk was 1.0% for patients without AKI, 1.8% for patients with AKI stage 1 and 2.3% for patients with AKI stages 2
to 3. The adjusted HR for MI was 1.04 (95% CI, 0.71 to 1.51) for patients with AKI stage 1 and 1.51 (95% CI, 1.05 to 2.18)
for patients with AKI stages 2 to 3, compared with patients without AKI. We found no association between AKI and
stroke. The increased risk of heart failure and MI persisted in patients with renal recovery before discharge, although it
was less pronounced than in patients without renal recovery.
Conclusions: ICU patients surviving any stage of AKI are at increased three-year risk of heart failure, but not stroke. Only
AKI stages 2 to 3 are associated with increased MI risk.Introduction
Acute kidney injury (AKI), which occurs in 22% to 67%
of intensive care unit (ICU) patients [1-5], is associated
with increased risk of both chronic kidney disease
(CKD) and death [1-8].
AKI also may have long-term adverse cardiovascular
effects [9]. The potentially increased risk of cardiovascu-
lar disease following AKI might be mediated through* Correspondence: hg@clin.au.dk
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article, unless otherwise stated.chronic renal impairment, a well-known risk factor of
cardiovascular disease [10]. In addition, animal studies have
shown that AKI causes a systematic inflammatory response
and activation of the renin-angiotensin system, subsequently
promoting apoptosis and interstitial/perivascular fibrosis in
the myocardium, and ultimately cardiac dysfunction [11,12].
These findings are supported by a few cohort studies
in humans, which reported that patients with AKI as a
complication to myocardial infarction (MI), coronary
intervention, or heart failure (HF) have an increased risk of
subsequent HF and MI [13-18]. AKI during hospitalization
also increases the risk of subsequent HF in patients infectedentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 KDIGO serum creatinine classification of acute
kidney injury [24]
Stage Serum creatinine criteria
1 1.5-1.9 times baseline
OR
≥ 26.5 5 μmol/l (0.3 mg/dl) increase within 48 hoursa
2 2.0-2.9 times baseline
3 ≥ 3.0 times baseline
OR
Increase in serum creatinine to≥ 354 μmol/l (4.0 mg/dl)b
OR
Initiation of renal replacement therapy
aWe defined 48 hours as two calendar days; btogether with fulfillment of any
of the other criteria for acute kidney injury. KDIGO, Kidney Disease Improving
Global Outcomes.
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it is not known whether AKI has similar implications
for incident HF and MI among ICU patients, among
whom AKI is common [1-5]. Although it has been sug-
gested that AKI may increase stroke risk [20], the po-
tential association between AKI and long-term stroke
risk has received little attention [13].
We therefore conducted a population-based cohort
study to examine (1) the impact of AKI on three-year
risk of first-time HF, MI, and stroke among ICU patients
surviving to hospital discharge, and (2) whether recovery
of renal function before hospital discharge modifies sub-
sequent risk of these cardiovascular diseases.
Methods
Setting
We conducted this cohort study using population-based
medical databases in Northern Denmark with approxi-
mately 1.15 million inhabitants.
The Danish health care system provides tax-funded
health care to all Danish residents. The study region has
12 ICUs, eight at university hospitals (one cardiothoracic,
one mixed cardiothoracic and multidisciplinary, one mixed
neurosurgery and multidisciplinary, one neurosurgical,
and four multidisciplinary) and four at regional hospi-
tals (all multidisciplinary). The unique civil registration
number assigned to all Danish residents allowed us to
link Danish medical and administrative databases [21].
Intensive care patients
We used the Danish National Registry of Patients (DNRP)
covering all Danish hospitals to identify all adult residents
of Northern Denmark (aged 15 years or older) who had
a first-time ICU admission from 1 January 2005 to 31
December 2010 and who survived to hospital dis-
charge. We required one year of residency in the study
region to ensure availability of previous test results from
the regional laboratory database. The study period was
chosen based on availability of data. The DNRP includes
data on all nonpsychiatric hospitalizations in Denmark
since 1977. Since 1995, the DNRP also has included
data from outpatient clinic visits, emergency room
visits, and psychiatric units. The DNRP records pa-
tients’ civil registration number, treating hospital and
department, dates of admission and discharge, type of
admission (emergency vs. planned), surgical and other
major procedures performed, ICU admissions and treat-
ments, and one primary and up to 19 secondary discharge
diagnoses assigned by the discharging physician. According
to Danish guidelines, the primary diagnosis is the main
reason for the hospital admission. Since 1994, discharge
diagnoses have been coded using the International
Classification of Diseases, 10th revision (ICD-10) [22].
We used the primary ICD-10 diagnosis for the currenthospitalization to categorize patients into one of the
following eight major disease groups: infectious disease,
endocrine disease, cardiovascular disease, respiratory dis-
ease, gastrointestinal or liver disease, cancer, trauma or poi-
soning, and other. In addition, we categorized patients into
five groups according to surgical status: no surgery, acute
cardiac surgery, acute noncardiac surgery, elective cardiac
surgery, and elective noncardiac surgery [6].
Acute kidney injury
We used the population-based laboratory database that
covers the study region to identify occurrences of AKI.
The laboratory database contains test results from all in-
patient stays, outpatient clinic visits, and visits to general
practitioners [23]. We classified AKI according to the
serum creatinine criteria in the Kidney Disease Improving
Global Outcome (KDIGO) AKI classification (Table 1)
[24]. We searched the laboratory database for the highest
plasma creatinine (equivalent to serum creatinine [25])
value from ICU admission until hospital discharge to
determine the highest level of AKI. All other ICU pa-
tients were classified as being ‘without AKI’. We de-
fined the baseline creatinine level as the most recent
creatinine measurement from an outpatient clinic or
general practitioner visit in the period from one year
to seven days before the current hospitalization [26].
Plasma creatinine assessments later than seven days
before the current hospitalization were not considered,
because acute renal impairment may precede the admis-
sion. For patients without CKD who lacked a baseline cre-
atinine measurement, we estimated baseline creatinine
using the four-variable version of the Modification of Diet
in Renal Disease (MDRD) equation based on age, race,
and gender, as recommended by the Second International
Consensus Conference of the Acute Dialysis Quality
Initiative (ADQI) Group [27]. Patients previously treated
with chronic dialysis or hemofiltration, those with a
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on plasma creatinine levels following ICU admission were
excluded from the study.
Heart failure, myocardial infarction, and stroke
Study outcomes were any hospital admission with a
diagnosis of HF, MI, or stroke (ischemic and hemorrhagic
cerebral stroke) registered in the DNRP subsequent to the
current hospital admission up to three years after hospital
discharge. In order to exclude prevalent cases, we omitted
all patients with any previous diagnosis of HF, MI, or
stroke up to 10 years prior to or during the admission.
Renal recovery at hospital discharge
Patients were considered to have achieved renal recovery
at hospital discharge if they did not receive any type of
dialysis or hemofiltration treatment up to seven days be-
fore hospital discharge and their last plasma creatinine
measurement before discharge was less than 50% above
their baseline level, that is, they no longer fulfilled the
criteria for AKI [28].
Covariates
We obtained data on covariates potentially associated with
both AKI and the study outcomes from the DNRP [22],
the laboratory database [23], and the Aarhus University
Prescription Database covering all community pharmacies
in the study region [29].
Data on comorbidities were primarily obtained from
the DNRP, including inpatient or outpatient clinic diag-
noses up to 10 years before the current hospitalization.
Because many patients with diabetes are treated outside
hospitals, we also defined patients as having diabetes if
they had a hemoglobin A1c level at or above 6.5% [30]
in the laboratory database up to one year before the
current admission or had any prescription for an antidia-
betic drug (insulin or oral antidiabetic agent) in the Aarhus
University Prescription Database up to five years before the
current admission. Diabetes patients who were identified
solely by a prescription of metformin and who had coexist-
ing polycystic ovary syndrome were classified as not having
diabetes. The Aarhus University Prescription Database
contains information on all filled drug prescriptions in
the study region. Variables included in this database are
patients’ civil registration number, type of drug according
to the Anatomic Therapeutic Chemical Classification
System (ATC), dosage, and prescription date [29]. In-
formation on CKD was obtained from the laboratory
database, defined as estimated glomerular filtration
rate (eGFR) below 60 ml/min per 1.73 m2 using the
four-variable MDRD equation (stage 3 or higher CKD
according to National Kidney Foundation guidelines) [24].
We used the most recent plasma creatinine measurement
from an outpatient clinic or general practitioner visit withinone year to seven days before the current hospitalization to
compute the eGFR [26]. Patients lacking a plasma creatin-
ine measurement were considered as not having CKD. We
also retrieved information on preadmission drug use, de-
fined as a prescription filled from 90 days before the current
hospitalization until hospital admission [31]. Information
was obtained for all drugs listed in Table 2.
All relevant codes used to retrieve data from the DNRP,
the laboratory database, and the Aarhus University
Prescription Database are provided in Additional file 1.
Statistical analyses
For each outcome, we followed patients from date of hos-
pital discharge for up to three years or until first-time hos-
pital admission with a study outcome of death or the end of
follow-up on 31 December 2011, whichever came first.
We used the cumulative incidence method to plot and
compute the crude three-year cumulative risk of admission
with HF, MI, or stroke for patients with AKI stage 1, AKI
stages 2 to 3, and those without AKI, taking death into
account as a competing risk [32]. Using hazard ratios
(HRs) computed with Cox regression models, we com-
pared the risk of each outcome for patients with AKI
stage 1 and AKI stages 2 to 3 with that of patients without
AKI [33]. In multivariate analyses we adjusted for the
following potential confounders: age, gender, other heart
disease, other cerebrovascular disease, hypertension, per-
ipheral vascular disease, diabetes, CKD, cancer, surgical
status at ICU admission, primary diagnosis during current
hospitalization, and preadmission use of any drug listed
in Table 2. To examine the influence of renal recovery
on subsequent cardiovascular disease risk, we stratified
the analysis by renal recovery status at hospital dis-
charge. All estimates were reported with 95% confi-
dence intervals (CI).
We conducted a sensitivity analysis to examine the
potential influence of excluding patients without a plasma
creatinine measurement for each outcome of interest.
We imputed AKI levels for patient without a creatinine
measurement using multiple imputation [34-36]. HRs
for each outcome was calculated as the average HR of
the five datasets, corrected for between- and within-
imputation variation [34-36]. The imputation models
included all variables in Table 2, the outcome of interest,
and the Nelson Aalen estimator of the cumulative baseline
hazard evaluated at the observed survival time [37].
The assumption of proportional hazards for all Cox
regression models was assessed graphically using log
(−log(survival probability))-plots and found valid. Analyses
were performed using the statistical software package Stata,
version 11.1 (StataCorp LP, College Station, TX, USA).
All data were obtained from Danish registries, which are
generally available to researchers without ethics approval
or informed consent [38,39]. The study was approved by
Table 2 Patient characteristics by AKI status among ICU patients surviving to hospital discharge, Northern Denmark,
2005 to 2010
Without AKI AKI stage 1 AKI stages 2-3
n = 16,764 n = 2,666 n = 2,126
Age
Age, median (IQR) 57 (39-69) 68 (58-77) 67 (56-75)
Gender
Female 7,788 (46.5) 1,031 (38.7) 944 (44.4)
Male 8,976 (53.5) 1,635 (61.3) 1,182 (55.6)
Comorbidity
Ischemic heart disease except MIa 1,863 (11.1) 513 (19.2) 244 (11.5)
Cerebrovascular disease except strokeb 537 (3.2) 124 (4.7) 86 (4.0)
Diabetes 1,490 (8.9) 460 (17.3) 433 (20.4)
Chronic kidney disease 1,063 (6.3) 502 (18.8) 338 (15.9)
Hypertension 2,216 (13.2) 664 (24.9) 511 (24.0)
Peripheral vascular disease 721 (4.3) 266 (10.0) 202 (9.5)
Cancer 2,282 (13.6) 522 (19.6) 375 (17.6)
No surgery 6,455 (38.5) 662 (24.8) 793 (37.3)
Surgery
Acute cardiac surgery 195 (1.2) 88 (3.3) 59 (2.8)
Acute noncardiac surgery 5,558 (33.2) 834 (31.3) 764 (35.9)
Elective cardiac surgery 1,701 (10.1) 528 (19.8) 169 (7.9)
Elective noncardiac surgery 2,855 (17.0) 554 (20.8) 341 (16.0)
Preadmission drug use
ACE inhibitors/AT2 antagonists 2,677 (16.0) 763 (28.6) 698 (32.8)
Beta blockers 2,318 (13.8) 667 (25.0) 487 (22.9)
Calcium channel antagonists 1,587 (9.5) 483 (18.1) 401 (18.9)
Acetylsalicylic acid 5,286 (31.5) 1,362 (51.1) 1,005 (47.3)
Diuretics 1,348 (8.0) 357 (13.4) 272 (12.8)
Nitrates 756 (4.5) 236 (8.9) 83 (3.9)
Statins 2,533 (15.1) 671 (25.2) 441 (20.7)
NSAIDs 2,486 (14.8) 430 (16.1) 436 (20.5)
Primary diagnosis during current hospitalization
Infectious diseases 1,673 (10.0) 276 (10.4) 434 (20.4)
Endocrine diseases 302 (1.8) 69 (2.6) 99 (4.7)
Cardiovascular diseases 2,910 (17.4) 873 (32.7) 390 (18.3)
Respiratory diseases 741 (4.4) 118 (4.4) 108 (5.1)
Gastrointestinal or liver diseases 1,564 (9.3) 287 (10.8) 303 (14.3)
Cancer or other neoplasm 2,463 (14.7) 471 (17.7) 304 (14.3)
Trauma or poisoning 4,198 (25.0) 282 (10.6) 190 (8.9)
Other 2,913 (17.4) 290 (10.9) 298 (14.0)
Laboratory information
Measured baseline creatinine 10,213 (60.9) 2,143 (80.4) 1,610 (75.7)
Maximum creatinine during admission,c μmol/l, mean (IQR) 74 (62-88) 123 (101-149) 254 (180-397)
ICU treatments
Mechanical ventilation 4,362 (26.0) 1,297 (48.6) 1,126 (53.0)
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Table 2 Patient characteristics by AKI status among ICU patients surviving to hospital discharge, Northern Denmark,
2005 to 2010 (Continued)
Inotropes/vasopressors 3,083 (18.4) 1,158 (43.4) 1,155 (52.9)
Length of admission
In-hospital daysd, median (IQR) 8 (3-15) 15 (10-28) 23 (12-45)
Values are expressed as number (percentage) unless otherwise indicated. aPatients with a previous diagnosis of myocardial infarction were not included in the
study; bpatients with a previous diagnosis of stroke were not included in the study; cfrom ICU admission until hospital discharge; dfrom hospital admission to
hospital discharge. If date of discharge from one department and/or hospital and admission to another department and/or hospital was ≤1 calendar day, this was
considered as one hospital admission. ACE, angiotensin-converting enzyme; AKI, acute kidney injury; AT2, angiotensin 2; ICU, intensive care unit; IQR interquartile
range; n, number; NSAIDS, nonsteroidal anti-inflammatory drugs.
Figure 1 Three-year crude cumulative incidence of heart
failure, myocardial infarction, and stroke by AKI stage. AKI,
acute kidney injury.
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Results
Characteristics of the study population
The study population comprised 21,556 ICU patients
who survived to hospital discharge, after excluding those
with a previous kidney transplant or chronic dialysis
treatment (n = 314), those with a previous or concurrent
diagnosis of HF, MI, or stroke (n = 6,702), and those lacking
a plasma creatinine measurement upon or after ICU admis-
sion (n = 1,846). Compared to patients with a plasma cre-
atinine measurement, patients lacking this measurement
were younger, had less comorbidity, and had a markedly
shorter hospital stay (Additional file 2). Median duration of
follow-up was 2.7 years for all three study outcomes.
We found that 4,792 (22.2%) of the 21,556 ICU patients
had an episode of AKI; 2,666 (12.4%) with AKI stage 1
and 2,126 (9.9%) with AKI stages 2 to 3. Patients with AKI
were older, more often male, and had a higher degree of
comorbidity than other ICU patients. AKI patients also
were more frequently users of cardiovascular drugs and
nonsteroidal anti-inflammatory drugs (NSAIDs) (Table 2).
The primary diagnosis during the current hospitalization
was most frequently trauma and poisoning for patients
without AKI (25.0%), cardiovascular disease for patients
with AKI stage 1 (32.7%), and infectious disease for pa-
tients with AKI stages 2 to 3 (20.4%). Patients with AKI
were more frequently treated with mechanical ventila-
tion and inotropes/vasopressors and had longer hospital
stays (Table 2). During follow-up, 2,569 (15.3%) died with-
out AKI, 619 (23.3%) with AKI stage 1 and 558 (26.2%)
with AKI stages 2 to 3.
Risk of heart failure
During the three years following hospital discharge, 2.2%
of patients without AKI, 5.0% of patients with AKI stage
1, and 5.0% of patients with AKI stages 2 to 3 were
hospitalized with first-time HF (Figure 1 and Table 3).
Compared to patients without AKI, the adjusted HR
was 1.33 (95% CI, 1.06 to 1.66) for patients with AKI
stage 1 and 1.45 (95% CI, 1.14 to 1.84) for patients with
AKI stages 2 to 3 (Table 3).
Table 3 Three-year risk of cardiovascular disease according to AKI stage, Northern Denmark, 2005 to 2010
Without AKI AKI stage 1 AKI stages 2-3
Events, n Cumulative risk
% (95% CI)












HF 320 2.2 (2.0–2.5) 114 5.0 (4.2–6.0) 2.43 (1.96–3.01) 1.33 (1.06–1.66) 91 5.0 (4.0–6.1 2.53 (2.01–3.01) 1.45 (1.14–1.84)
MI 135 1.0 (0.8–1.2) 38 1.8 (1.3–2.4) 1.93 (1.35–2.76) 1.04 (0.71–1.51) 40 2.3 (1.7–3.1) 2.68 (1.88–3.82) 1.51 (1.05–2.18)
Stroke 131 0.9 (0.8–1.1) 35 1.7 (1.2–2.4) 1.83 (1.26–2.65) 1.10 (0.75–1.62) 26 1.4 (1.0–2.1) 1.79 (1.17–2.72) 1.07 (0.70–1.65)
aAdjusted for age, gender, other ischemic heart diseases, other cerebrovascular diseases, hypertension, peripheral vascular disease, diabetes, chronic kidney disease, cancer, surgical status, primary diagnosis during















Table 4 Three-year risk of cardiovascular disease
stratified by renal recovery status at hospital dischargea
Recovery (n = 3,888) Nonrecovery (n = 904)
Events Adjusted HRb Events Adjusted HRb
n (95% CI) n (95% CI)
AKI stage 1
Heart failure 98 1.26 (1.00-1.60) 15 1.81 (1.07-3.07)
Myocardial
infarction
35 1.05 (0.72-1.55) 3 0.79 (0.25-2.51)
Stroke 32 1.142 (0.77-1.70) 3 0.98 (0.31-3.10)
AKI stages 2-3
Heart failure 62 1.50 (1.13-1.98) 30 1.42 (0.96-2.10)
Myocardial
infarction
23 1.31 (0.83-2.07) 17 1.97 (1.17-3.32)
Stroke 19 1.16 (0.71-1.90) 7 0.94 (0.43-2.04)
aCompared to ICU patients without AKI; badjusted for age, gender, other
ischemic heart diseases, other cerebrovascular diseases, hypertension,
peripheral vascular disease, diabetes, chronic kidney disease, cancer, surgical
status, primary diagnosis during current hospitalization, and preadmission use
of drugs listed in Table 2.
AKI, acute kidney injury; CI, confidence interval; HR, hazard ratio; ICU, intensive
care unit; n, number.
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The three-year cumulative risk of MI was 1.0% for patients
without AKI, 1.8% for patients with AKI stage 1 and 2.3%
for patients with AKI stages 2 to 3 (Figure 1 and Table 3).
The adjusted HR was 1.04 (95% CI, 0.71 to 1.51) for pa-
tients with AKI stage 1 and 1.51 (95% CI, 1.05 to 2.18) for
patients with AKI stages 2 to 3 (Table 3).
Risk of stroke
Stroke risk within the first three years after hospital
discharge was 0.9% for patients without AKI, 1.7% for
patients with AKI stage 1, and 1.4% for patients with
AKI stages 2 to 3 (Figure 1 and Table 3). The adjusted
HRs were 1.10 (95% CI, 0.75 to 1.62) for patients with
AKI stage 1 and 1.07 (95% CI, 0.70 to 1.65) for patients
with AKI stages 2 to 3 (Table 3).
Renal recovery
Of the 4,792 ICU patients with AKI who survived to hos-
pital discharge, 3,888 (81.1%) recovered renal function by
the time of discharge. The increased risk of HF following
any stage of AKI and of MI following AKI stages 2 to 3
persisted in patients who recovered their renal function,
although their risk was lower than among patients without
renal recovery (Table 4).
Sensitivity analysis
The associations between AKI and heart failure, MI and
stroke were similar after imputation of AKI level in patients
without a measured plasma creatinine upon or after ICU
admission. Please see Additional file 3.
Discussion
In this population-based study of more than 21,000 ICU
survivors, patients with AKI stages 2 to 3 were at 50%
increased risk of HF and MI in the three-year follow-up
period. Even AKI stage 1 was associated with increased
risk of HF. The increased risk persisted in patients who
recovered their renal function by the time of hospital
discharge, but was less pronounced than the risk among
patients without recovery of renal function. No associa-
tions were found between AKI and stroke or between
AKI stage 1 and MI.
Other studies
Our study is the first to examine the impact of AKI on
first-time hospitalization for HF, MI, and stroke follow-
ing an ICU stay. Previous studies primarily examined the
impact on subsequent cardiovascular disease of AKI sec-
ondary to HF, MI or coronary intervention [13-18], and
none focused on first-time cardiovascular events [13-19].
Five earlier studies examined the impact of AKI on HF
[13-16,19]. Similar to our findings among ICU patients
with AKI, they reported that AKI, as a complication ofcoronary angiography [13], MI [14], coronary arterial by-
pass grafting (CABG) surgery [15], HF [16], and HIV
[19] increased the risk of hospitalization for subsequent
HF. In a Canadian cohort of 14,782 patients who under-
went coronary angiography, procedures complicated by
AKI were associated with increased risk of subsequent
hospital admission for HF after median follow-up of 20
months. The adjusted HRs ranged from 1.48 (95% CI,
1.16 to 1.91) for patients with AKI stage 1 to 2.17 (95%
CI, 1.49 to 3.15) for patients with AKI stages 2 to 3 [13].
Similarly, a single-center Israeli study of 1,957 patients
admitted for ST-elevation MI found that during median
follow-up of 36 months AKI was associated with subse-
quent risk of HF among patients who survived until hos-
pital discharge. This study also found that the association
persisted in patients who recovered renal function before
hospital discharge, which our findings confirmed [14]. A
large Swedish study of 24,018 patients who underwent
CABG surgery found that among 30-day survivors the ad-
justed HR of HF during mean follow-up of 4.1 years was
1.69 (95% CI, 1.48 to 1.94), 2.33 (95% CI, 1.69 to 3.22) and
1.87 (95% CI, 0.84 to 4.20) for AKI stages 1, 2 and 3, re-
spectively [15]. The association between AKI and subse-
quent increased risk of HF was also evident in a cohort of
US veterans with HIV who survived the first three months
after hospital discharge. Choi et al. reported an adjusted
HR of subsequent HF of 1.17 (95% CI, 1.34 to 2.35) in
patients with stage 1 AKI, 2.11 (95% CI, 1.07 to 2.35)
in patients with AKI stages 2 to 3 not requiring dialysis,
and 4.20 (95% CI, 2.24 to 7.88) in patients with AKI
stages 2 to 3 requiring dialysis, during mean follow-up of
5.7 years [19]. In addition, a Chinese single-center study
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complicated by AKI were readmitted more frequently
for HF during the following year [16].
A few studies have examined risk of MI after AKI in
different study populations [13,14,17,18]. Like our ICU
study, they found that AKI was associated with later MI.
However, these relatively small studies were hampered by
imprecise risk estimates [13,14]. The study by James et al.
found that the adjusted HRs of MI complicated by AKI stage
1 and AKI stages 2 to 3 were 1.47 (95% CI, 1.12 to 1.91)
and 1.19 (95% CI, 0.70 to 2.02), respectively, compared
with non-AKI patients. The Israeli study by Goldberg et al.
found that the adjusted HR of recurrent MI after initial MI
complicated by AKI was 1.6 (95% CI, 0.9 to 1.8) for patients
with mild AKI who did not regain renal function by
hospital discharge, 1.4 (95% CI, 0.7 to 3.0) for patients
with moderate/severe AKI who did regain renal function,
and 1.4 (95% CI, 0.7 to 2.8) for those with moderate/severe
AKI who did not recover renal function. However, they
found no increased risk of MI among patients with mild
AKI who regained renal function (adjusted HR = 0.6
(95% CI, 0.2 to 1.8). In their single-center study, Lindsay
et al. found that AKI (serum creatinine >50% over baseline)
after percutaneous intervention was associated with a
twofold increased risk of MI among hospital survivors
(adjusted OR = 2.0; 95% CI, 1.3 to 3.2). A Danish single-
center study among elective cardiac surgical patients found
a nonsignificant association between AKI and increased MI
risk (five-year adjusted HR = 1.5 (95% CI, 0.7 to 3.2)) [18].
To our knowledge, only two studies have examined the
association between AKI and long-term (beyond 90 days)
risk of stroke [13,18]. In line with our results, these studies
did not find marked evidence for an association between
AKI and subsequent hospitalization with stroke [13,18].
Strengths and limitations
The main strengths of this study are its population-
based design in the setting of a uniform tax-supported
health care system providing equal access to health care.
As well, patient follow-up was virtually complete, and
data on ICU admissions were highly valid. This reduced
potential selection bias.
Several limitations should be considered when inter-
preting our results. First, like most other studies of AKI,
we lacked data on urine output and thus could not
include the urine output criteria specified in the KDIGO
classification. Therefore, we may have underestimated
the prevalence of AKI compared to the use of both plasma
creatinine and urine output criteria [40]. Second, we ex-
cluded patients without measured plasma creatinine upon
or after ICU admission, which potentially could introduce
selection bias. However, our results were similar after
imputation of AKI level for patients without a plasma
creatinine measurement. Third, despite the fact thatwe had access to all plasma creatinine measurements
for outpatient clinic or general practitioner visits in the
study area, we did not have a measured baseline cre-
atinine for 35% of the ICU patients. We therefore esti-
mated baseline creatinine as previously suggested [27].
This may, however, underestimate the AKI prevalence in
patients without CKD [41]. In addition, even a measured
plasma creatinine measurement from an outpatient clinic
or a general practitioner visit, which was available in 65%
of the included patients, may not truly reflect a baseline
creatinine level. Fourth, our outcome assessment relies on
correct coding. Previous studies have found that the posi-
tive predictive values of discharge diagnoses recorded for
HF, MI, and stroke are 81% [42], 92% [43], and 84% [44],
respectively. However, any misclassification is expected to
be nondifferential, biasing the study toward a null result.
Fifth, we had few outcomes for MI and stroke, resulting in
imprecise estimates. Six, patients with coexisting HF may
have been undiagnosed due to this disease’s asymptomatic
nature in its early phase. The association between AKI
and apparent subsequent HF therefore could be partly
due to reverse causation. Finally, although we controlled
for potential confounders using highly valid data on
known comorbidities and drug use, our results may
have been affected by unmeasured or residual confound-
ing, such as undiagnosed cardiac dysfunction and severity
of various comorbidities.Conclusions
AKI stages 2 to 3 in surviving ICU patients is associated
with increased risk of HF and MI up to three years after
hospital discharge. The association of HF was evident
even among patients with AKI stage 1. These associa-
tions were less pronounced but persisted among patients
who had recovered renal function by hospital discharge.
This may suggest a need for systematic follow-up of pa-
tients discharged after an AKI episode, especially those
who do not regain their renal function before discharge.Key messages
 Acute kidney injury is associated with increased risk of
heart failure and myocardial infarction, but not stroke.
 The increased risk of heart failure and myocardial
infarction persisted among patients who had
recovered renal function by hospital discharge.Additional files
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